title: [Six cases of pulmonary MALT lymphoma: a heterogeneous therapeutic management].
abstract: Pulmonary mucosa-associated lymphoid tissue lymphomas (PMALT) account for around 1% of lymphomas. Clinical and radiological presentations, and the treatment of six PMALT were collected from 1993 to 2008. All patients received chemotherapy before disease progression. Two patients had a lobectomy and one received thoracic radiotherapy. In 2008, all the patients were alive and three were in remission. A "watch and wait" strategy is widely accepted for stable, asymptomatic patients and patients with low tumour mass. Surgery may be proposed for symptomatic patients who have localised PMALT. When a chemotherapy treatment is to be suggested, chlorambucil-based chemotherapy is preferred. There may be room for rituximab alone or in combination, but this remains to be precisely defined. Several larger studies are currently ongoing to assess the role of monoclonal antibodies and chemotherapy in MALT lymphomas. Subgroup analysis should help us to define the optimal treatment for PMALT.
authors.affiliation: Service d'hématologie et d'oncologie médicale, centre Antoine-Lacassagne, Nice cedex, France. sabine.marco@wanadoo.fr
authors.forename: S
authors.initials: S
authors.lastname: Marco
authors.forename: J
authors.initials: J
authors.lastname: Thariat
authors.forename: M
authors.initials: M
authors.lastname: Poudenx
authors.forename: C
authors.initials: C
authors.lastname: Butori
authors.forename: J
authors.initials: J
authors.lastname: Mouroux
authors.forename: J-G
authors.initials: JG
authors.lastname: Fuzibet
authors.forename: C-H
authors.initials: CH
authors.lastname: Marquette
authors.forename: F
authors.initials: F
authors.lastname: Peyrade
authors.forename: A
authors.initials: A
authors.lastname: Thyss
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D002699:Chlorambucil / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011013:Pneumonectomy; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D000069283:Rituximab; D016896:Treatment Outcome; D057832:Watchful Waiting
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D002699:Chlorambucil; D000069283:Rituximab